LANCET 润色咨询

LANCET

出版年份:1823 年文章数:2161 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:2.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2023-06-20 ms6000002144421454 来自上海

    昨天decision in progress今天with editor了正常么

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2024-02-24 朝天之阙 来自广西

    审稿速度:12.0 | 投稿命中率:5.0
    偏重的研究方向:综合
    经验分享:评论型letter准备七个月,还是with editor,非常慢。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2022-06-08 Spider

    偏重的研究方向:肿瘤
    经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。

    15

    展开15条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2022-01-16 17748b9278m

    审稿速度:1.0
    经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2023-06-19 4031828 来自河南省

    投稿后焦虑

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2023-06-01 4031828 来自河南省

    看看别人投稿的经验,自己学习一下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2023-03-24 采药者 来自广东省

    偏重的研究方向:公共卫生
    经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2022-07-31 芥末鳕鱼511

    想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=2143946, encodeId=2bb52143946e0, content=昨天decision in progress今天with editor了正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Tue Jun 20 20:00:41 CST 2023, time=2023-06-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2189049, encodeId=44af218904944, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:综合<br>经验分享:评论型letter准备七个月,还是with editor,非常慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23963312341, createdName=朝天之阙, createdTime=Sat Feb 24 11:28:45 CST 2024, time=2024-02-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2615, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143652, encodeId=f788214365218, content=投稿后焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 19 13:29:15 CST 2023, time=2023-06-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1235823, encodeId=0090123582315, content=想请问下大家,clinical picture投了2天,编辑回复建议transfer 到AACE clinial case reports,不知道这个杂志什么情况呀?梅斯医学里也查不到IF值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=664a2050311, createdName=芥末鳕鱼511, createdTime=Sun Jul 31 22:10:36 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560240, encodeId=701f56024020, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1498, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bf91969609, createdName=doctor wan, createdTime=Sun Aug 19 23:49:00 CST 2018, time=2018-08-19, status=1, ipAttribution=)]
    2018-08-19 doctor wan

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:投稿了clinical picture栏目十余天,一直是with editor,估计是离拒稿不远了吧

    3

    展开3条回复
共119条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分